Organismes de services de gestion : Questions médicales fréquentes
Nom anglais: Management Service Organizations
Descriptor UI:D021661
Tree Number:N04.452.758.372
Termes MeSH sélectionnés :
RNA, Long Noncoding
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Organismes de services de gestion : Questions médicales les plus fréquentes",
"headline": "Organismes de services de gestion : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Organismes de services de gestion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-03",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Organismes de services de gestion"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pratique professionnelle",
"url": "https://questionsmedicales.fr/mesh/D011364",
"about": {
"@type": "MedicalCondition",
"name": "Pratique professionnelle",
"code": {
"@type": "MedicalCode",
"code": "D011364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452.758"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Organismes de services de gestion",
"alternateName": "Management Service Organizations",
"code": {
"@type": "MedicalCode",
"code": "D021661",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Aminu K Bello",
"url": "https://questionsmedicales.fr/author/Aminu%20K%20Bello",
"affiliation": {
"@type": "Organization",
"name": "Division of Nephrology and Immunology, Department of Medicine, University of Alberta Edmonton, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Vivekanand Jha",
"url": "https://questionsmedicales.fr/author/Vivekanand%20Jha",
"affiliation": {
"@type": "Organization",
"name": "George Institute for Global Health, University of New South Wales, New Delhi, India."
}
},
{
"@type": "Person",
"name": "Adeera Levin",
"url": "https://questionsmedicales.fr/author/Adeera%20Levin",
"affiliation": {
"@type": "Organization",
"name": "Nephrology Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada."
}
},
{
"@type": "Person",
"name": "Marcello Tonelli",
"url": "https://questionsmedicales.fr/author/Marcello%20Tonelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Calgary, Calgary, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Syed Saad",
"url": "https://questionsmedicales.fr/author/Syed%20Saad",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Alberta, Edmonton, Alberta, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35907193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/2022.5.JNS22579"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of the long noncoding RNA transcriptome in human preimplantation embryo development.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37770818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10815-023-02951-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37611624",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1772705"
}
},
{
"@type": "ScholarlyArticle",
"name": "The long intergenic noncoding RNA ARES modulates root architecture in Arabidopsis.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37409758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/iub.2761"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long Noncoding RNA UCA1 Correlates With Electropathology in Patients With Atrial Fibrillation.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37227342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jacep.2023.02.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pratique professionnelle",
"item": "https://questionsmedicales.fr/mesh/D011364"
},
{
"@type": "ListItem",
"position": 5,
"name": "Organismes de services de gestion",
"item": "https://questionsmedicales.fr/mesh/D021661"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Organismes de services de gestion - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Organismes de services de gestion",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Organismes de services de gestion",
"description": "Comment identifier un OSG ?\nQuels services offrent les OSG ?\nQuels sont les types d'OSG ?\nComment évaluer l'efficacité d'un OSG ?\nQuels outils utilisent les OSG ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=RNA,+Long+Noncoding&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Organismes de services de gestion",
"description": "Quels signes indiquent un besoin d'OSG ?\nComment reconnaître une mauvaise gestion ?\nQuels impacts d'une mauvaise gestion ?\nQuels symptômes d'une surcharge administrative ?\nComment détecter des erreurs fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=RNA,+Long+Noncoding&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Organismes de services de gestion",
"description": "Comment prévenir les erreurs de gestion ?\nQuelles pratiques recommandées pour les OSG ?\nComment assurer la conformité réglementaire ?\nQuels outils pour la prévention des risques ?\nComment sensibiliser le personnel aux OSG ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=RNA,+Long+Noncoding&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Organismes de services de gestion",
"description": "Comment un OSG améliore-t-il la gestion ?\nQuels outils de gestion sont recommandés ?\nComment former le personnel à l'OSG ?\nQuels sont les bénéfices d'un OSG ?\nComment évaluer un OSG ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=RNA,+Long+Noncoding&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Organismes de services de gestion",
"description": "Quelles complications d'une mauvaise gestion ?\nComment une mauvaise gestion affecte-t-elle les soins ?\nQuels risques d'une surcharge administrative ?\nComment gérer les plaintes des patients ?\nQuelles conséquences d'une non-conformité ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=RNA,+Long+Noncoding&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Organismes de services de gestion",
"description": "Quels facteurs augmentent le besoin d'OSG ?\nComment la technologie influence-t-elle les OSG ?\nQuels sont les risques liés à la gestion interne ?\nComment le marché affecte-t-il les OSG ?\nQuels impacts des changements réglementaires ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=RNA,+Long+Noncoding&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un OSG ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un OSG est identifié par ses services de gestion administrative et de soutien aux pratiques médicales."
}
},
{
"@type": "Question",
"name": "Quels services offrent les OSG ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les OSG offrent des services tels que la facturation, la gestion des ressources humaines et le soutien technologique."
}
},
{
"@type": "Question",
"name": "Quels sont les types d'OSG ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les types d'OSG incluent ceux spécialisés en facturation, en gestion de la qualité et en conformité réglementaire."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un OSG ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité d'un OSG peut être évaluée par des indicateurs de performance tels que la satisfaction des clients et la réduction des coûts."
}
},
{
"@type": "Question",
"name": "Quels outils utilisent les OSG ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les OSG utilisent des logiciels de gestion, des systèmes de facturation et des plateformes de communication."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un besoin d'OSG ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent une surcharge administrative, des erreurs fréquentes et une mauvaise gestion du temps."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une mauvaise gestion ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise gestion se manifeste par des retards dans les paiements, des plaintes de patients et des audits défavorables."
}
},
{
"@type": "Question",
"name": "Quels impacts d'une mauvaise gestion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les impacts incluent une baisse de la qualité des soins, une insatisfaction des patients et des pertes financières."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une surcharge administrative ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent le stress du personnel, des délais prolongés et une communication inefficace."
}
},
{
"@type": "Question",
"name": "Comment détecter des erreurs fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des audits réguliers et des retours d'expérience des employés aident à détecter les erreurs fréquentes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les erreurs de gestion ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des formations régulières, des audits et l'utilisation de technologies adaptées."
}
},
{
"@type": "Question",
"name": "Quelles pratiques recommandées pour les OSG ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les pratiques recommandées incluent la standardisation des processus et la mise en place de contrôles internes."
}
},
{
"@type": "Question",
"name": "Comment assurer la conformité réglementaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Assurer la conformité nécessite des audits réguliers et une mise à jour continue des connaissances réglementaires."
}
},
{
"@type": "Question",
"name": "Quels outils pour la prévention des risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme les logiciels de gestion des risques et les plateformes de communication sont utiles."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le personnel aux OSG ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sensibilisation peut se faire par des formations, des réunions d'équipe et des bulletins d'information."
}
},
{
"@type": "Question",
"name": "Comment un OSG améliore-t-il la gestion ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un OSG améliore la gestion en optimisant les processus, réduisant les coûts et augmentant l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels outils de gestion sont recommandés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme les logiciels de gestion de cabinet et les systèmes de facturation sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment former le personnel à l'OSG ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La formation peut inclure des ateliers, des sessions de coaching et des modules en ligne sur les outils de gestion."
}
},
{
"@type": "Question",
"name": "Quels sont les bénéfices d'un OSG ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bénéfices incluent une meilleure gestion des ressources, une réduction des coûts et une satisfaction accrue des patients."
}
},
{
"@type": "Question",
"name": "Comment évaluer un OSG ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des indicateurs de performance, des retours d'expérience et des audits réguliers."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une mauvaise gestion ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des pertes financières, des plaintes de patients et des sanctions réglementaires."
}
},
{
"@type": "Question",
"name": "Comment une mauvaise gestion affecte-t-elle les soins ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des retards dans les soins, une qualité inférieure et une insatisfaction des patients."
}
},
{
"@type": "Question",
"name": "Quels risques d'une surcharge administrative ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent le burnout du personnel, des erreurs de traitement et une communication défaillante."
}
},
{
"@type": "Question",
"name": "Comment gérer les plaintes des patients ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des plaintes nécessite une écoute active, une réponse rapide et des actions correctives."
}
},
{
"@type": "Question",
"name": "Quelles conséquences d'une non-conformité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences incluent des amendes, des pertes de licence et une réputation ternie."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le besoin d'OSG ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la taille de la pratique, la complexité des opérations et les changements réglementaires."
}
},
{
"@type": "Question",
"name": "Comment la technologie influence-t-elle les OSG ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "La technologie influence les OSG en améliorant l'efficacité, la communication et la gestion des données."
}
},
{
"@type": "Question",
"name": "Quels sont les risques liés à la gestion interne ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent le manque de formation, la résistance au changement et des processus obsolètes."
}
},
{
"@type": "Question",
"name": "Comment le marché affecte-t-il les OSG ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fluctuations du marché peuvent influencer la demande de services et la rentabilité des OSG."
}
},
{
"@type": "Question",
"name": "Quels impacts des changements réglementaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les changements réglementaires peuvent nécessiter des ajustements rapides et des formations supplémentaires."
}
}
]
}
]
}
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive stenosis of the internal carotid artery (ICA) and secondary formation of collateral vessels. Revascularization sur...
The authors collected microsamples of the middle cerebral artery (MCA) from patients with MMD (n = 21) and patients with control conditions (n = 11) who underwent neurosurgical treatment. Using microa...
The authors detected 308 differentially expressed lncRNAs (fold change > 2, q < 0.05), including 306 upregulated and 2 downregulated lncRNAs in the MCA from patients with MMD. Regarding the prediction...
The profile of lncRNA expression in MMD lesions was different from that in the normal cerebral artery, and differentially expressed lncRNAs were identified. This study provides new insights into the p...
Infertility remains a human health burden globally. Only a fraction of embryos produced via assisted reproductive technologies (ARTs) develop to the blastocyst stage in vitro. lncRNA abundance changes...
scRNA-seq data and SUPeR-seq data were used to investigate the lncRNA profiles of human preimplantation embryos. The top 50 highly expressed unique and shared lncRNAs in each stage of preimplantation ...
The lncRNA profiles of human preimplantation embryos in the E-MTAB-3929 dataset were similar to those in the GSE71318 dataset. The ratios of overlap among the top 50 highly expressed lncRNAs between t...
Our study paves the way for understanding the regulation of developmental events, which might be beneficial for improved reproductive outcomes....
Mitochondrial dysfunction is a recognized factor in the pathogenesis of deep vein thrombosis (DVT). The role of 7S RNA, a long noncoding RNA that plays an important role in mitochondrial function, in ...
Long noncoding RNAs (lncRNAs) have emerged as important regulators of gene expression in plants. They have been linked to a wide range of molecular mechanisms, including epigenetics, miRNA activity, R...
Perpetuation of atrial fibrillation (AF) is rooted in derailment of molecular proteostasis pathways that cause electrical conduction disorders that drive AF. Emerging evidence indicates a role for lon...
In the present study, the authors explored the association between 3 cardiac lncRNAs and the degree of electropathology....
Patients had paroxysmal AF (ParAF) (n = 59), persistent AF (PerAF) (n = 56), or normal sinus rhythm without a history of AF (SR) (n = 70). The relative expression levels of urothelial carcinoma-associ...
The expression levels of SARRAH and LIPCAR were decreased in RAAs of all AF patients compared with SR. Also, in RAAs, UCA1 levels significantly correlated with the percentage of conduction block and d...
LncRNAs SARRAH and LIPCAR are reduced in RAA of AF patients, and UCA1 levels correlate with electrophysiologic conduction abnormalities. Thus, RAA UCA1 levels may aid staging of electropathology sever...
Long non coding RNAs (lncRNAs) are involved in the tumor growth, invasion, metastasis, and cancer recurrence. The improper expression of certain lncRNAs is correlated with the prognosis of the cancer ...
Renal cell carcinoma is one of the common cancers whose incidence and mortality are continuously growing worldwide. Initially, this type of tumour is usually asymptomatic. Due to the lack of reliable ...
Parkinson's disease (PD) is a neurodegenerative disease resulted from the loss of dopaminergic neurons. Here, we analyzed the role of long noncoding RNA (lncRNA) small nucleolar RNA host gene 14 (SNHG...
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot assay were performed to determine RNA and protein expression, respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-dip...
MPP...
SNHG14 promoted MPP...
Hepatocellular carcinoma (HCC) and pancreatic cancer (PC) are among serious malignancies with no proper biomarker suffering from poor prognosis and late onset. Regulation of long noncoding RNAs (lncRN...
Tumor necrosis factor-α (TNF-α) and heterogenous nuclear ribonucleoprotein L (hnRNPL)-related immunoregulatory lincRNA (THRIL) is a long noncoding RNA (lncRNA) involved in various inflammatory disease...